Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 102.00 1,875 08:00:21
Bid Price Offer Price High Price Low Price Open Price
102.00 106.00 0.00 0.00 0.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -28.44 -36.17 67
Last Trade Time Trade Type Trade Size Trade Price Currency
08:14:15 O 1,875 102.60 GBX

4d Pharma (DDDD) Latest News

More 4d Pharma News
4d Pharma Takeover Rumours

4d Pharma (DDDD) Discussions and Chat

4d Pharma Forums and Chat

Date Time Title Posts
04/12/201916:534D Pharma 2018 - from Ј2 back up to Ј10+238
14/3/201922:074D Pharma (DDDD) One to Watch 7
25/6/201810:414d Pharma160

Add a New Thread

4d Pharma (DDDD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-12-11 17:02:47102.00193196.85O
2019-12-11 16:35:00102.00861878.22UT
2019-12-11 16:25:14102.00424432.48AT
2019-12-11 16:09:41102.00479488.58AT
View all 4d Pharma trades in real-time

4d Pharma (DDDD) Top Chat Posts

4d Pharma Daily Update: 4d Pharma Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker DDDD. The last closing price for 4d Pharma was 102p.
4d Pharma Plc has a 4 week average price of 87.50p and a 12 week average price of 65p.
The 1 year high share price is 147.50p while the 1 year low share price is currently 65p.
There are currently 65,493,842 shares in issue and the average daily traded volume is 104,485 shares. The market capitalisation of 4d Pharma Plc is £66,803,718.84.
ch1ck: I'm just reviewing my holding and noted I have an unusually large holding in this stock so wanted to check there was still a reason to hold. looking back at previous announcements I thought I would repost this: Company has entered into a research collaboration and option to license agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth, NJ, USA, to discover and develop Live Biotherapeutics ("LBPs") for vaccines. Under the terms of the agreement 4D's proprietary MicroRx® platform will be paired with MSD's expertise in the development and commercialisation of novel vaccines, to discover and develop LBPs as vaccines in up to three undisclosed indications. 4D has the right, subject to certain conditions, to cause MSD to purchase $5 million in ordinary shares in 4D during the first 12 months of the collaboration. In addition to an upfront cash payment, for each indication, 4D will be eligible to receive up to $347.5 million in option exercise and development and regulatory milestone payments, plus tiered royalties on annual net sales of any licensed products derived from the collaboration. MSD will be responsible for development, manufacturing and commercialisation following the exercise of any of its exclusive options. This would indicate that the clock is ticking for 4D to get drugs through phase 2 and three and also Merck to pull the trigger if they want to buy options. Recent buys in the tens of millions would indicate that there is appetite for the stock and this could explode up on any good news or insider trading. Remember Woodford for all his failings did his research and bought in. (don't hold that against the stock) Finally I ran some overlays on the 1, 3 and 5year charts and it looks like the 50 day moving average is about to cross the 200 and will do this if the day price moves through 120p which I looks like a possibility. This is defiantly not a risk free stock but one I'm happy to hold and add to if the share price moves through 100p
ch1ck: Société Général decided to invest in just under 6.5 Million shares last week. This was done with the shares trading around these levels. Shares have retraced back to the same level with what seems to be low volume of shares sold.This would seem to indicate that shares will be in shorter supply meaning if we have another player looking to invest in 4D the share price will push up with support.The next few weeks will be very interesting. I have decided to take a fairly large position here
someuwin: 4D pharma plc (the "Company" or "4D") Trading Update 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, notes the recent fall in its share price, and confirms that it is not aware of any Company related matter which could be responsible for this price movement. The Board also confirms that all clinical study timelines continue to progress as expected.
jamjason: James Henderson said the share price should never have gone as high as it did. Talk about kicking yourself in the foot!
someuwin: Article in Today's Shares Magazine. James Henderson from Lowland Investment Company... "...He also likes drug company 4D Pharma (DDDD:AIM) which he calls a well-funded company with drugs being tested and which has an attractive tie-up with pharma giant Merck. 'Sometimes stocks get overhyped and people get bored of them so the share price drifts. That's happened with 4D Pharma yet real progress is being made with its portfolio."
onedayrodders: really ... how hypocritical is that !!! LOL !! Vanduke - 14 Jun 2018 - 10:19:15 - 2321 of 2324 OptiBiotix - The uncensored thread - OPTI Nearly three years of no share price gains. Pointless non-revenue based RNS. Promises of no further placing, then one at 62p with the usual BS justification by management (capital for growth scam). Deals with P&G, Slimfast, TATA and many more all gone quite. You couldn't make it up. Vanduke - 14 Jun 2018 - 10:09:27 - 2320 of 2324 OptiBiotix - The uncensored thread - OPTI 62p placing price broken soon. Then 44p Vanduke - 14 Jun 2018 - 09:57:50 - 2319 of 2324 OptiBiotix - The uncensored thread - OPTI You have to laugh.. Pathetic really.. Let them continue the illusion Vanduke - 12 Jun 2018 - 09:12:49 - 2318 of 2324 OptiBiotix - The uncensored thread - OPTI So much hard work ramping and producing pointless RNS. OPTI still remains in long-term downtrend. No revenues, just all hot air... Vanduke - 24 May 2018 - 11:34:18 - 2252 of 2324 OptiBiotix - The uncensored thread - OPTI Still in downtrend. All the BS RNS have failed Vanduke - 23 May 2018 - 08:24:42 - 2248 of 2324 OptiBiotix - The uncensored thread - OPTI Never held bioprogres. But an OPTI in progress. Vanduke - 23 May 2018 - 08:01:44 - 2246 of 2324 OptiBiotix - The uncensored thread - OPTI Appalling results. No substance. Worthless agreements. No real business... Vanduke - 23 May 2018 - 07:58:18 - 2244 of 2324 OptiBiotix - The uncensored thread - OPTI So much BS in the results. Very selective 're information. Mis-information continues Vanduke - 23 May 2018 - 07:54:56 - 2243 of 2324 OptiBiotix - The uncensored thread - OPTI 44p soon.. True value £25 million at best...
ch1ck: SomeuwinYes your right. The share price has flattened and hopefully forming a line of resistance. The share price has been hammered way below fair value. With new products being pushed into trials we could see a rapid spike up with any good news.Exciting times
sharpshare: 4d Pharma PLC Ticker: DDDD Issued shares: 60,567,729 Latest share price: 540p Mkt cap: £327,065,736 OptiBiotix Health PLC Ticker: OPTI Issued Shares: 72,430,397 Latest share price: 20.5p Mkt cap: £14,848,231 Just 22x higher share price for OPTI to 451p to catch up with DDDD mkt cap.
4d Pharma share price data is direct from the London Stock Exchange
Your Recent History
4d Pharma
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191212 08:29:57